Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Ischemic Heart Disease

  Free Subscription

Articles published in Mayo Clin Proc

Retrieve available abstracts of 47 articles:
HTML format

Single Articles

    October 2021
  1. BELL EJ, Bielinski SJ, St Sauver JL, Chen LY, et al
    Association of Proton Pump Inhibitors With Higher Risk of Cardiovascular Disease and Heart Failure.
    Mayo Clin Proc. 2021;96:2540-2549.
    PubMed     Abstract available

  2. MALIK N, Weintraub WS
    The Cardiovascular Risk of Proton Pump Inhibitors and the Dangers of Polypharmacy.
    Mayo Clin Proc. 2021;96:2511-2513.

    September 2021
  3. SHARAIN K, Vasile VC, Sandoval Y, Donato LJ, et al
    The Elevated High-Sensitivity Cardiac Troponin T Pilot: Diagnoses and Outcomes.
    Mayo Clin Proc. 2021;96:2366-2375.
    PubMed     Abstract available

    August 2021
  4. PETERMANN-ROCHA F, Ho FK, Foster H, Boopor J, et al
    Nonlinear Associations Between Cumulative Dietary Risk Factors and Cardiovascular Diseases, Cancer, and All-Cause Mortality: A Prospective Cohort Study From UK Biobank.
    Mayo Clin Proc. 2021 Aug 5. pii: S0025-6196(21)00226.
    PubMed     Abstract available

  5. WHELTON SP, McAuley PA, Dardari Z, Orimoloye OA, et al
    Fitness and Mortality Among Persons 70 Years and Older Across the Spectrum of Cardiovascular Disease Risk Factor Burden: The FIT Project.
    Mayo Clin Proc. 2021 Aug 5. pii: S0025-6196(21)00132.
    PubMed     Abstract available

  6. PATEL N, Narasimhan B, Bandyopadhyay D, Amreia M, et al
    Impact of Pulmonary Hypertension on In-Hospital Outcomes and 30-Day Readmissions Following Percutaneous Coronary Interventions.
    Mayo Clin Proc. 2021;96:2058-2066.
    PubMed     Abstract available

  7. KHAN SS, Agarwal A, Ayers CR, Jin E, et al
    Effects of Empagliflozin Treatment on Cardiac Biomarkers in Adults With Metabolically Healthy Obesity: Results From a Randomized, Placebo-Controlled Clinical Trial.
    Mayo Clin Proc. 2021;96:2282-2284.

    July 2021
  8. ONO R, Umehara N
    Multiple Giant Coronary Artery Aneurysms in Kawasaki Disease.
    Mayo Clin Proc. 2021;96:1888-1889.

  9. KIM Y, Hwang S, Sharp SJ, Luo S, et al
    Genetic Risk, Muscle Strength, and Incident Stroke: Findings From the UK Biobank Study.
    Mayo Clin Proc. 2021;96:1746-1757.
    PubMed     Abstract available

    June 2021
  10. CORBAN MT, Toya T, Ahmad A, Lerman LO, et al
    Atrial Fibrillation and Endothelial Dysfunction: A Potential Link?
    Mayo Clin Proc. 2021;96:1609-1621.
    PubMed     Abstract available

    May 2021
  11. LUIS SA, Luis CR, Habibian M, Lwin MT, et al
    Prognostic Value of Cardiac Magnetic Resonance Imaging in Acute Coronary Syndrome Patients With Troponin Elevation and Nonobstructive Coronary Arteries.
    Mayo Clin Proc. 2021 May 12. pii: S0025-6196(20)31388.
    PubMed     Abstract available

  12. KLOECKER DE, Khunti K, Davies MJ, Pitocco D, et al
    Microvascular Disease and Risk of Cardiovascular Events and Death From Intensive Treatment in Type 2 Diabetes: The ACCORDION Study.
    Mayo Clin Proc. 2021 May 2. pii: S0025-6196(20)31114.
    PubMed     Abstract available

  13. TSENG AS, Girardo M, Firth C, Bhatt S, et al
    Lower Extremity Arterial Disease as a Predictor of Incident Atrial Fibrillation and Cardiovascular Events.
    Mayo Clin Proc. 2021;96:1175-1183.
    PubMed     Abstract available

    April 2021
  14. PARCHA V, Kalra R, Best AF, Patel N, et al
    Geographic Inequalities in Cardiovascular Mortality in the United States: 1999 to 2018.
    Mayo Clin Proc. 2021 Apr 8. pii: S0025-6196(20)30987.
    PubMed     Abstract available

  15. GUPTA K, Kalra R, Pate M, Nagalli S, et al
    Relative Predictive Value of Circulating Immune Markers in US Adults Without Cardiovascular Disease: Implications for Risk Reclassification.
    Mayo Clin Proc. 2021 Apr 8. pii: S0025-6196(20)31389.
    PubMed     Abstract available

  16. FERDINAND KC, Nedunchezhian S
    Physical Activity: Necessary, But Not Adequate Alone, to Overcome Disparities in Cardiovascular Disease in African Americans.
    Mayo Clin Proc. 2021;96:844-846.

  17. MEYER MR
    Chronic Coronary Syndromes in Women: Challenges in Diagnosis and Management.
    Mayo Clin Proc. 2021;96:1058-1070.
    PubMed     Abstract available

  18. NATH KA
    In the Limelight: April 2021.
    Mayo Clin Proc. 2021;96:835-837.

  19. DEVOE JE
    Getting Primary Care - A Life-Saving Intervention - Off Life Support.
    Mayo Clin Proc. 2021;96:870-874.

    March 2021
  20. PARCHA V, Kalra R, Suri SS, Malla G, et al
    Geographic Variation in Cardiovascular Health Among American Adults.
    Mayo Clin Proc. 2021 Mar 25. pii: S0025-6196(21)00053.
    PubMed     Abstract available

  21. KAMIMURA D, Cain-Shields LR, Clark D, Oshunbade AA, et al
    Physical Activity, Inflammation, Coronary Artery Calcification, and Incident Coronary Heart Disease in African Americans: Insights From the Jackson Heart Study.
    Mayo Clin Proc. 2021 Mar 10. pii: S0025-6196(20)31375.
    PubMed     Abstract available

  22. RITTER O, Kararigas G
    In Reply - COVID-19, the Female Immune Advantage, and Cardiovascular Impact.
    Mayo Clin Proc. 2021;96:821-822.

  23. GERSH FL, O'Keefe JH, Henry BM
    COVID-19, the Female Immune Advantage, and Cardiovascular Impact.
    Mayo Clin Proc. 2021;96:820-821.

  24. NAARAAYAN A, Nimkar A, Jesmajian S, Gitler B, et al
    Atherosclerotic Cardiovascular Disease Prevalence Among Patients With Celiac Disease in the United States: An Observational Study.
    Mayo Clin Proc. 2021;96:666-676.
    PubMed     Abstract available

  25. BARILLAS-LARA MI, Medina-Inojosa JR, Kolla BP, Smith JR, et al
    The Association of Sleep Apnea and Cardiorespiratory Fitness With Long-Term Major Cardiovascular Events.
    Mayo Clin Proc. 2021;96:636-647.
    PubMed     Abstract available

  26. PASTORI D, Menichelli D, Del Sole F, Pignatelli P, et al
    Long-Term Risk of Major Adverse Cardiac Events in Atrial Fibrillation Patients on Direct Oral Anticoagulants.
    Mayo Clin Proc. 2021;96:658-665.
    PubMed     Abstract available

    February 2021
  27. LAVIE CJ, Milani RV, Laukkanen JA, Bernasconi AA, et al
    In Reply-Impact of a High-Shrimp Diet on Cardiovascular Risk: An NHANES Analysis.
    Mayo Clin Proc. 2021;96:508.

  28. NARASIMHAN B, Kaplin S, Wang Z, Krittanawong C, et al
    Impact of a High-Shrimp Diet on Cardiovascular Risk: An NHANES Analysis.
    Mayo Clin Proc. 2021;96:506-508.

  29. HSIAO SH, Hwang TJ, Lin FJ, Sheu JJ, et al
    The Association Between the Use of Cholinesterase Inhibitors and Cardiovascular Events Among Older Patients With Alzheimer Disease.
    Mayo Clin Proc. 2021;96:350-362.
    PubMed     Abstract available

  30. FARUKHI ZM, Mora S, Manson JE
    Marine Omega-3 Fatty Acids and Cardiovascular Disease Prevention: Seeking Clearer Water.
    Mayo Clin Proc. 2021;96:277-279.

  31. NATH KA
    In the Limelight: February 2021.
    Mayo Clin Proc. 2021;96:269-271.

    January 2021
  32. SHOAIB A, Mohamed M, Rashid M, Khan SU, et al
    Clinical Characteristics, Management Strategies and Outcomes of Acute Myocardial Infarction Patients With Prior Coronary Artery Bypass Grafting.
    Mayo Clin Proc. 2021;96:120-131.
    PubMed     Abstract available

  33. ORRINGER CE, Maki KC
    In Reply-Coronary Artery Calcium Scores I and II.
    Mayo Clin Proc. 2021;96:262-263.

    Coronary Artery Calcium Scores II.
    Mayo Clin Proc. 2021;96:262.

    Coronary Artery Calcium Scores I.
    Mayo Clin Proc. 2021;96:261.

    December 2020
  36. RASHID M, Nagaraja V, Shoaib A, Curzen N, et al
    Outcomes Following Percutaneous Coronary Intervention in Renal Transplant Recipients: A Binational Collaborative Analysis.
    Mayo Clin Proc. 2020 Dec 23. pii: S0025-6196(20)30830.
    PubMed     Abstract available

  37. ALKHOULI M, Alqahtani F, Jneid H, Al Hajji M, et al
    Age-Stratified Sex-Related Differences in the Incidence, Management, and Outcomes of Acute Myocardial Infarction.
    Mayo Clin Proc. 2020 Dec 9. pii: S0025-6196(20)30846.
    PubMed     Abstract available

  38. PERAVALI R, Muddassir K
    Rare Cause of Acute Myocardial Infarction.
    Mayo Clin Proc. 2020;95:2697-2698.

  39. AGARWAL MA, Ziaeian B, Lavie CJ, Fonarow GC, et al
    Cardiovascular Disease in Hospitalized Patients With a Diagnosis of Coronavirus From the Pre-COVID-19 Era in United States: National Analysis From 2016-2017.
    Mayo Clin Proc. 2020;95:2674-2683.
    PubMed     Abstract available

    November 2020
  40. MOHAMED MO, Roddy E, Ya'qoub L, Myint PK, et al
    Acute Myocardial Infarction in Autoimmune Rheumatologic Disease: A Nationwide Analysis of Clinical Outcomes and Predictors of Management Strategy.
    Mayo Clin Proc. 2020 Nov 25. pii: S0025-6196(20)30829.
    PubMed     Abstract available

  41. POWELL MJ, Dufault SM, Gunderson EP, Benz CC, et al
    Cancer and Cardiovascular Risk in Women With Hypertensive Disorders of Pregnancy Carrying a Common IGF1R Variant.
    Mayo Clin Proc. 2020 Nov 6. pii: S0025-6196(20)30652.
    PubMed     Abstract available

  42. ALKHOULI M, Rihal CS
    In reply-Risk Framing in Cardiovascular Medicine I and II.
    Mayo Clin Proc. 2020;95:2569-2571.

  43. TREJO-GUTIERREZ JF, Eng-Cecena L
    Risk Framing in Cardiovascular Medicine II.
    Mayo Clin Proc. 2020;95:2569.

  44. MODARRESSI T, Derakhshan A
    Risk Framing in Cardiovascular Medicine I.
    Mayo Clin Proc. 2020;95:2568-2569.

    Disrupting Common Practice: Retiring Stress Tests for Acute Chest Pain Presentations.
    Mayo Clin Proc. 2020;95:2356-2359.

  46. FOSTER HME, Ho FK, Sattar N, Welsh P, et al
    Understanding How Much TV is Too Much: A Nonlinear Analysis of the Association Between Television Viewing Time and Adverse Health Outcomes.
    Mayo Clin Proc. 2020;95:2429-2441.
    PubMed     Abstract available

    September 2020
  47. BERNASCONI AA, Wiest MM, Lavie CJ, Milani RV, et al
    Effect of Omega-3 Dosage on Cardiovascular Outcomes: An Updated Meta-Analysis and Meta-Regression of Interventional Trials.
    Mayo Clin Proc. 2020 Sep 17. pii: S0025-6196(20)30985.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.